For a drugmaker advancing medicines through clinical trials, time is the enemy: the longer the process takes, the more costs ...

Yet, one analyst told Barron’s that “rarely in my 20 years as an analyst have I seen a company with so much potential.” He ...

We recently published a list of 8 Best Small-Cap Growth Stocks to Buy According to Analysts. In this article, we are going to ...

Investing in Cabaletta Bio for potential high returns on innovative CAR-T therapies despite volatility and risk. Click here ...

The crisis that has swept the biotech sector crashed into Medpace Holdings on Tuesday, sending shares of the drug-testing ...

After upwardly revising terms and offering more shares at pricing, biotech Septerna (SEPN) raised $288 million at a $797 ...

If Kevin and Stephanie Ness collect their $15 million asking price for the home on Sunset Blvd., it will be the second time ...

Septerna CEO Jeffrey Finer rang the opening bell on the Nasd | South San Francisco-based Septerna has scored with an upsized ...

ISRO & Department of Biotechnology have come together to conduct a series of biotech experiments in space, some of which are ...

Discover top biotech associations that drive industry growth through collaboration, networking, and strategic partnerships ...

North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global ...

Shortly after Bicara Therapeutics raised more than $360 million in an IPO, the cancer biotech and its former parent company ...